PT1131072E - Preparacoes de uma combinacao farmaceutica na forma de dosagem solida de carvedilol e hidroclorotiazida - Google Patents

Preparacoes de uma combinacao farmaceutica na forma de dosagem solida de carvedilol e hidroclorotiazida

Info

Publication number
PT1131072E
PT1131072E PT99957320T PT99957320T PT1131072E PT 1131072 E PT1131072 E PT 1131072E PT 99957320 T PT99957320 T PT 99957320T PT 99957320 T PT99957320 T PT 99957320T PT 1131072 E PT1131072 E PT 1131072E
Authority
PT
Portugal
Prior art keywords
carvedilol
hydrochlorothiazide
preparations
dose
pharmaceutical combination
Prior art date
Application number
PT99957320T
Other languages
English (en)
Inventor
Rudolf Heller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1131072(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT1131072E publication Critical patent/PT1131072E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT99957320T 1998-11-27 1999-11-20 Preparacoes de uma combinacao farmaceutica na forma de dosagem solida de carvedilol e hidroclorotiazida PT1131072E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122489 1998-11-27

Publications (1)

Publication Number Publication Date
PT1131072E true PT1131072E (pt) 2003-08-29

Family

ID=8233041

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99957320T PT1131072E (pt) 1998-11-27 1999-11-20 Preparacoes de uma combinacao farmaceutica na forma de dosagem solida de carvedilol e hidroclorotiazida

Country Status (22)

Country Link
US (3) US6403579B1 (pt)
EP (1) EP1131072B1 (pt)
JP (2) JP2002531395A (pt)
KR (1) KR100421347B1 (pt)
CN (1) CN1184971C (pt)
AR (1) AR020287A1 (pt)
AT (1) ATE238056T1 (pt)
AU (1) AU765977B2 (pt)
BR (1) BR9915610A (pt)
CA (1) CA2352361C (pt)
CO (1) CO5011053A1 (pt)
DE (1) DE69907252T2 (pt)
DK (1) DK1131072T3 (pt)
ES (1) ES2195638T3 (pt)
MY (1) MY121831A (pt)
PE (1) PE20001302A1 (pt)
PT (1) PT1131072E (pt)
TR (3) TR200200982T2 (pt)
TW (1) TWI228414B (pt)
UY (1) UY25821A1 (pt)
WO (1) WO2000032174A2 (pt)
ZA (1) ZA200104280B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
JP2004518734A (ja) * 2000-10-24 2004-06-24 スミスクライン・ビーチャム・コーポレイション カルベジロールの新規処方
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
IN191028B (pt) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1499310A4 (en) * 2002-04-30 2005-12-07 Sb Pharmco Inc MONOCITRATE MONOHYDRATE OF CARVEDILOL
WO2004002472A1 (en) 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
JP2005533823A (ja) 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド リン酸カルベジロール塩および／またはその溶媒和物、対応する組成物、および／または治療方法
EP1562552A1 (en) 2002-11-08 2005-08-17 Egalet A/S Controlled release carvedilol compositions
EP2301526B1 (en) 2003-03-26 2016-03-23 Egalet Ltd. Morphine controlled release system
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
AU2003272851A1 (en) * 2003-09-26 2005-04-14 Shuyi Zhang Sustained release preparation containing hydrochlorothiazide
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
JP5072364B2 (ja) * 2003-11-25 2012-11-14 スミスクライン ビーチャム （コーク） リミテッド カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
EP1686986A4 (en) 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
JP2007513114A (ja) * 2003-12-02 2007-05-24 ニコックス エス エイ 抗高血圧薬としてのカルベジロール及びその他のベータ遮断薬のニトロオキシ誘導体
BRPI0606187A2 (pt) * 2005-02-25 2009-06-09 Hoffmann La Roche comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
WO2007144175A2 (en) * 2006-06-16 2007-12-21 Lek Pharmaceuticals D.D. Pharmaceutical composition comprising hydrochlorothiazide and telmisartan
GB0612540D0 (en) * 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
WO2008114276A1 (en) * 2007-03-16 2008-09-25 Lupin Limited Novel oral controlled release composition of carvedilol
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations
WO2011110347A2 (en) * 2010-03-10 2011-09-15 Giuliani International Limited Compositions for colon lavage and methods of making and using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

Also Published As

Publication number Publication date
KR20010080578A (ko) 2001-08-22
CN1328460A (zh) 2001-12-26
TWI228414B (en) 2005-03-01
TR200200981T2 (tr) 2002-06-21
WO2000032174A2 (en) 2000-06-08
MY121831A (en) 2006-02-28
US20020052367A1 (en) 2002-05-02
DK1131072T3 (da) 2003-08-11
UY25821A1 (es) 2001-07-31
CA2352361A1 (en) 2000-06-08
ZA200104280B (en) 2002-08-26
BR9915610A (pt) 2001-08-14
ATE238056T1 (de) 2003-05-15
EP1131072A2 (en) 2001-09-12
AU1506500A (en) 2000-06-19
TR200101470T2 (tr) 2001-11-21
ES2195638T3 (es) 2003-12-01
TR200200982T2 (tr) 2002-06-21
KR100421347B1 (ko) 2004-03-06
CN1184971C (zh) 2005-01-19
JP2002531395A (ja) 2002-09-24
AR020287A1 (es) 2002-05-02
CO5011053A1 (es) 2001-02-28
US6403579B1 (en) 2002-06-11
EP1131072B1 (en) 2003-04-23
DE69907252T2 (de) 2004-01-29
DE69907252D1 (de) 2003-05-28
WO2000032174A3 (en) 2000-11-16
JP2007077160A (ja) 2007-03-29
US20040087578A1 (en) 2004-05-06
AU765977B2 (en) 2003-10-09
PE20001302A1 (es) 2000-11-30
CA2352361C (en) 2007-01-02

Similar Documents

Publication Publication Date Title
PT1131072E (pt) Preparacoes de uma combinacao farmaceutica na forma de dosagem solida de carvedilol e hidroclorotiazida
NO20003219D0 (no) Oralfarmasøytisk doseringsform med pulsert frigivningsvirkning
DK1043976T3 (da) Oral farmaceutisk doseringsform med langvarig frigivelse
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
EE04566B1 (et) Epotilooni derivaadid ja nende kasutamine meditsiinis
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
HUP0101137A3 (en) Anticoagulant amidines and their pharmaceutical use
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
DE69415570T2 (de) Esculetin Derivate und pharmazeutische Zusammenstellung
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
DE69809928D1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
DE69813624D1 (de) Gemisch und pharmazeutische zubereitung enthaltend z-4-hydroxytamoxifen und cyclodextrin
ATE338548T1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
DE60034963D1 (de) Heterocyclische derivate und arzneistoffe
DE19681529D2 (de) Pharmazeutische Darreichungsform